Metronidazole Injection Shortage: FDA Update
Metronidazole Injection is currently listed in shortage by the FDA, an anti-infective medication, with one manufacturer reporting availability as of the latest update.
Metronidazole Injection Shortage
As a professional health news writer for Areazine, we aim to provide empathetic and informative coverage of drug shortages that may affect patients relying on these medications.
What's in Shortage
The generic drug name is Metronidazole Injection, with the brand name METRONIDAZOLE. It is available in injection dosage form and is currently in shortage status. It falls under the therapeutic category of Anti-Infective. The shortage was first posted on 01/13/2022 and last updated on 04/01/2026.
Which Manufacturers Are Affected
Baxter Healthcare is the manufacturer listed, and their product is available. Their specific presentation is Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48). For inquiries, their contact information is 888-229-0001.
Why There's a Shortage
No specific reason was provided for the shortage.
What Patients Should Do
Patients experiencing issues with obtaining this medication should speak with their pharmacist or healthcare provider to check availability. They can also inquire about general options and contact the manufacturer directly if needed. Please remember that patients should always consult their healthcare provider for personalized advice and not make changes without professional guidance.
Source
This information is sourced from the FDA Drug Shortage Database.
Source: FDA Official Notice